3 Einträge gefunden

1. Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial

   1. Facon, Thierry
   2. Kumar, Shaji K
   3. Plesner, Torben
   4. Orlowski, Robert Z
   5. Moreau, Philippe
   6. Bahlis, Nizar
   7. Basu, Supratik

   2021 - Forschungsinformationssystem des UKE
2. Evaluation of Sustained Minimal Residual Disease Negativity With Daratumumab-Combination Regimens in Relapsed and/or Refractory Multiple Myeloma: Analysis of POLLUX and CASTOR

   1. Avet-Loiseau, Hervé
   2. San-Miguel, Jesus
   3. Casneuf, Tineke
   4. Iida, Shinsuke
   5. Lonial, Sagar
   6. Usmani, Saad Z
   7. Spencer, Andrew

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. Health-Related Quality of Life in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: Findings From the Phase III MAIA Trial

   1. Perrot, Aurore
   2. Facon, Thierry
   3. Plesner, Torben
   4. Usmani, Saad Z
   5. Kumar, Shaji
   6. Bahlis, Nizar J
   7. Hulin, Cyrille

   2021 - Forschungsinformationssystem des UKE - frei zugänglich